FreedomWorks Originals provides you entertainment and education to help you better understand economics, the workings of government, and our insight into the most important debates facing our nation today. Watch and subscribe today!
Welcome to the new and improved Regulatory Action Center (RAC) Review! RAC proudly keeps you up to date on what we’re up to and what we’re keeping our eyes on here in the swamp. We offer resources for you to get involved in the rulemaking process to hold unelected bureaucrats accountable and occasionally offer praise in the event they have a good impulse. We will also highlight the incredible work our activists have done to advance the principles of smaller government, lower taxes, free markets, personal liberty, and the rule of law. For more ways to get involved and stay informed, check the links at the bottom of this post.
On Friday, President Trump issued three executive orders (and threatened a fourth) outlining sweeping changes he planned to make regarding prescription drug prices in the United States. One order seeks to make federal grants to federally qualified health centers contingent upon discounted insulin prices. A second would allow personal and wholesale importation of prescription drugs from overseas. The third implements rebate reform for pharmacy benefits managers (PBMs).
In his 2019 State of the Union Address, President Trump triumphantly proclaimed, “America will never be a socialist nation.” This line drew raucous applause from many in the House chamber and, surely, from many sitting and watching at home.
Prices for prescription drugs in the U.S. are far too high. There is no denying this sad reality. According to an analysis done by the House Ways and Means Committee, the U.S. pays roughly four times as much as 11 similar nations for prescription drugs. For millions of patients, families, and caregivers, this is unacceptable. Policymakers are right when they say something needs to be done.
WASHINGTON, D.C. -- In response to proposals by so-called free-market conservatives that call for the implementation of price controls on prescription drugs, FreedomWorks announces today a six-figure Hulu and digital ad buy calling on Congress and the administration to reject socialized price controls.
Last year, some supposedly conservative lawmakers - namely those within the Department of Health and Human Services (HHS) - shocked their admirers by endorsing price controls on prescription drugs. This proposal, known as the international price index (IPI), would tie the prices of Medicare drugs in the U.S. to prices in a select set of foreign nations. Many of those foreign nations already apply their own price controls.
WASHINGTON, D.C. -- In response to the House passage of the Patient Protection and Affordable Care Enhancement Act, H.R. 1425, on a largely party-line vote, Jason Pye, FreedomWorks Vice President of Legislative Affairs, commented:
FreedomWorks Foundation, American Legislative Exchange Council, Tea Party Patriots and Committee to Unleash Prosperity in partnership with a coalition of conservative organizations and prominent individuals, launched the Save Our Country Task Force.